AR226-2312 ^ Charles J Zaizecki 03/13/2003 03:48 PM To: cc: Subject: Catherine A Barton/AE/DuPont Fayetteville Results Cathie.
refid# nkeVdQLakX0YeK5oY7ObZZRD81 page
AR226-2595 JAiairew'sTtertTen """" ' " '" 08/23/2002 02:40 PM'| To: cc: Subject; M.
refid# Lgb5XEpzmZO1aLdBe1xzqjraz1 page
Analysis #0615.01 Revision 01 Supersedes Date: None Effective Date: Page 1 of 16 M,.-- 0,. 9,, AR226-2725 2,,0,.,0,,1 FG-143 in WaterWastewater by SPME/GCMS Reference: 1.
refid# 3evqa6VRrz1kxmg4JjqgQ90bD16 pages
AR226-2806 TRADE SECRET Study Title H-25537: Corrositex/nF7/7-oTest Laboratory Project ID: DuPont-12020 AUTHOR: Carol Finlay, B.A.
refid# 88JKnrb96nKr1R4md1de2D159 pages
31NIrvlEDICALDEPART?
refid# NG5Em47g4JKkZdze7XwQeEJ6y11 pages
CorporateHealthPhvsies Corporate IndustriaHlygiene& Erounumics CorporateoccupationalNledicine Corporate Toxicolo@3NI 'viedical Depar@nment 3M Center,Buildin2g20-2E-02 PO Box 332'-70 St.Pau',"@IN5@1 6 @@1 1 10 Nia,,,I -@
refid# v69nmXqkXEpkoE0kNYexNm0061 page
4 4 p.1 ~}t~ZZ6 -37 Presented at Socie ty of Toxicology 45th Annual Meeting San Diego, CA .
refid# JNya5JN3KGE82bOVq9e8wQraa11 pages
3M Specialty Materials ~~~ 3M Center P .
refid# KJODqN40KLe26BOvr7azN6a1K4 pages
p. 1 ~ ^ ~' -~ ~ ~' a /~ -~ C7ti ~ ~ /" Final Report Mortality of Employees of an Ammonium Perfluorooctanoate Production Facility Jessica I .
refid# G6J6MMEZw3zoBeo5dn878yNZ751 pages
AR22%6-0013 vou. 1 : .
refid# RaXw0ka0NKmLVo9VjBgXrEK73 pages
| ip 3M AR SSaief VriemPasntn, 22 i097 nMaSiafetymSerovesamon, - BRE Buoilndianng 4v22e6e.36 TH EYL PSUPO BorM33N531S533: 86HR _ 80. 00373 EMAL CERTIFI!
refid# pm4dZVQkYk65YDgM5R0BOnowX1 page
267 cron commen 13 AR eres 226 conn _ |S iTIrBEeT ne envensRIsbIZ2 10 Pa, 120m, 2002 To Hoa of Delgo tte JotMeetheCiranmigs Comitean th Working Pay on Chemicals, Pesticides and Biotechnology oo BNIaAtCi,onaTlUDAeCl,egaEtCioBns.
refid# RJOrmRVp6VVprVdXKjnxDav282 pages
on : con LE, RkoCsoerer oA,sareios r TELECOPY TAF' T, STET.TINIUS & HOLLISTERALLRPR26 1800 FIRSTAR TOWER 425 WALNUT STREET CINCINNATI, OHIO 45202-3957 wo 13T380E2000 -- June 10.2002 -- 1182 PB wd Sn Ee =g Z a3n3 = 55 Chris Negley, Esq.
refid# r6NevpEbrxq4eQR3NQJ0m07rE15 pages
} Aventis Pharma Aventis Pharma Deutschland GmbH Testing Facility Kastengrund ProTox Mainzer Landstr. 500 D- 65795 Hattersheim Germany AR226-1525 Aventis RECEIVED OPPT NCIC 03 SEP 30 PM1:00 TOXICOLOGY STUDY REPORT PT02-0222 T-7758 RAT REPEAT DOSE 28-DAY ORAL TOXICITY + 14-DAYS RECOVERY Author: Date: Original report for the sponsor Total pages: 464 Dr.
refid# Z4n3Qey19QpqowooxENVqOYYL464 pages
Attachments to Letter to C.
refid# QgOadLRybQ542Q1Vov9g41D977 pages